Overview

GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
To evaluate safety and efficacy of the combination cisplatin plus irinotecan in the treatment of biliary tract cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Hospital de Cancer de Barretos - Fundacao Pio XII
Treatments:
Antiemetics
Camptothecin
Cisplatin
Gemcitabine
Irinotecan